HOUSTON (AP) — HOUSTON (AP) — Alaunos Therapeutics, Inc. (TCRT) on Monday reported a loss of $8.8 million in its second quarter.
On a per-share basis, the Houston-based company said it had a loss of 4 cents.
The drug developer posted revenue of $4,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TCRT at https://www.zacks.com/ap/TCRT
For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.
, source Associated Press News